Department of Science and Medicine, University of Ottawa, 1728Ottawa, Canada
Short Communication
Developmental Treatment Progress for Atopic Dermatitis
Author(s): Zhou Paul*
Atopic Dermatitis (AD) is a chronic skin illness caused by complicated interactions between skin barrier
abnormalities and a deregulated immune system, which is characterized by the activation of diverse T cell subsets at
various phases of the disease. Until recently, the majority of patients were treated with moisturizers, topical steroids
and topical calcineurin inhibitors, with systemic immunosuppressant are being recommended in seriously sick
patients. New treatment techniques have been conceived and developed in recent years to target the many phases in
the chain of molecular processes that rise to the AD phenotype. The focus of this short communication will be on
current advancements in the treatment of Alzheimer's disease. .. View more»